Procalcitonin Test for Differentiation of the Cause of Pneumonia
NCT ID: NCT03350802
Last Updated: 2020-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
649 participants
OBSERVATIONAL
2014-01-01
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of High Risk Lung Cancer Screening
NCT03683940
Symptom Collection of Lung Cancer Patients
NCT03384680
A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females
NCT06181929
Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy
NCT02821949
A Multi-Center Trial of the ProLung Test™
NCT01566682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this prospective cohort study is to observe the clinical benefits of procalcitonin test for differentiation of the cause of pneumonia in patients with cancer.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
procalcitonin pneumonia cohort
Patients who are suspected of acute pneumonia due to symptoms and imaging findings compatible with pneumonia can be enrolled in this cohort.
procalcitonin test
All patients enrolled in this cohort undergo procalcitonin test in addition to basic microbiological test.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
procalcitonin test
All patients enrolled in this cohort undergo procalcitonin test in addition to basic microbiological test.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have symptoms and suspected imaging findings compatible with pneumonia
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Center, Korea
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hee Seok Lee
Pulmonologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
HEE SEOK LEE, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Respiratory Clinic, National Cancer Center
Goyang-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCC2014-0018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.